Engineered skin bacteria induce antitumor T cell responses against melanoma
First consumer genetic health test under the Quest brand provides insights based on DNA, with unique features that include next-generation sequencing, robust support services, physician ordering, and access to one-on-one genetic counseling SECAUCUS, N.J., July 11, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today announced the launch of its first consumer-initiated genetic test, now exclusively available through the company's consumer health business at questhealth.com
A favorable vote does not legalize compounding
Protection of halophytes and their uses for cultivation of Saline-Alkali soil in China
10.1590/1519-6984.228437 64 OharazawaH.IgarashiT.YokotaT.FujiiH.SuzukiH.MachideM
Clinical relevance of tumor fraction assessment from circulating tumor DNA in metastatic colorectal cancer